Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing

NCT04414397 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT04414397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
May 28, 2020
Completion date
October 17, 2022
Enrollment
205 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

temple hollowing